{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:40Z","timestamp":1790746720823,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T00:00:00Z","timestamp":1436918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10620-015-3706-9","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T10:17:10Z","timestamp":1436869030000},"page":"3044-3052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1"],"prefix":"10.1007","volume":"60","author":[{"given":"Guohui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaihong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"key":"3706_CR1","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2012.07.009","volume":"143","author":"T Chiba","year":"2012","unstructured":"Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143:550\u2013563.","journal-title":"Gastroenterology"},{"key":"3706_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.semcancer.2014.01.004","volume":"26","author":"A Shlomai","year":"2014","unstructured":"Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014;26:78\u201388.","journal-title":"Semin Cancer Biol"},{"key":"3706_CR3","first-page":"1081","volume":"12","author":"RW Pang","year":"2012","unstructured":"Pang RW, Poon RT. Cancer stem cell as a potential therapeutic target in hepatocellular carcinoma. Curr Cancer Drug Targets. 2012;12:1081\u20131094.","journal-title":"Curr Cancer Drug Targets"},{"key":"3706_CR4","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1053\/j.gastro.2012.04.007","volume":"142","author":"XW Wang","year":"2012","unstructured":"Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology. 2012;142:1431\u20131443.","journal-title":"Gastroenterology"},{"key":"3706_CR5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2011.11.026","volume":"56","author":"F Borel","year":"2012","unstructured":"Borel F, Konstantinova P, Jansen PL. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol. 2012;56:1371\u20131383.","journal-title":"J Hepatol"},{"key":"3706_CR6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2012.06.123","volume":"427","author":"Z Wang","year":"2012","unstructured":"Wang Z, Zhang X, Yang Z, et al. MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells. Biochem Biophys Res Commun. 2012;427:444\u2013449.","journal-title":"Biochem Biophys Res Commun"},{"key":"3706_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/1541-7786.MCR-12-0534","volume":"11","author":"L Zheng","year":"2013","unstructured":"Zheng L, Pu J, Qi T, et al. miRNA-145 targets v-ets erythroblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells. Mol Cancer Res. 2013;11:182\u2013193.","journal-title":"Mol Cancer Res"},{"key":"3706_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.canlet.2013.03.003","volume":"335","author":"JH Noh","year":"2013","unstructured":"Noh JH, Chang YG, Kim MG, et al. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett. 2013;335:455\u2013462.","journal-title":"Cancer Lett"},{"key":"3706_CR9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12020-014-0202-5","volume":"46","author":"J Sperveslage","year":"2014","unstructured":"Sperveslage J, Hoffmeister M, Henopp T, et al. Establishment of robust controls for the normalization of miRNA expression in neuroendocrine tumors of the ileum and pancreas. Endocrine. 2014;46:226\u2013230.","journal-title":"Endocrine"},{"key":"3706_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ijc.23583","volume":"123","author":"TS Wong","year":"2008","unstructured":"Wong TS, Liu XB, Chung-Wai HA, et al. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int J Cancer. 2008;123:251\u2013257.","journal-title":"Int J Cancer"},{"key":"3706_CR11","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1158\/0008-5472.CAN-07-6655","volume":"68","author":"J Datta","year":"2008","unstructured":"Datta J, Kutay H, Nasser MW, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008;68:5049\u20135058.","journal-title":"Cancer Res"},{"key":"3706_CR12","doi-asserted-by":"crossref","first-page":"33394","DOI":"10.1074\/jbc.M804788200","volume":"283","author":"MW Nasser","year":"2008","unstructured":"Nasser MW, Datta J, Nuovo G, et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem. 2008;283:33394\u201333405.","journal-title":"J Biol Chem"},{"key":"3706_CR13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.biocel.2005.05.004","volume":"37","author":"Y Hashimoto","year":"2005","unstructured":"Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol. 2005;37:1787\u20131804.","journal-title":"Int J Biochem Cell Biol"},{"key":"3706_CR14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cub.2009.12.035","volume":"20","author":"A Li","year":"2010","unstructured":"Li A, Dawson JC, Forero-Vargas M, et al. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol. 2010;20:339\u2013345.","journal-title":"Curr Biol"},{"key":"3706_CR15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PAS.0b013e3181db36c0","volume":"34","author":"C Chan","year":"2010","unstructured":"Chan C, Jankova L, Fung CL, et al. Fascin expression predicts survival after potentially curative resection of node-positive colon cancer. Am J Surg Pathol. 2010;34:656\u2013666.","journal-title":"Am J Surg Pathol"},{"key":"3706_CR16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/abbs\/gmp053","volume":"41","author":"H Fu","year":"2009","unstructured":"Fu H, Hu Z, Wen J, et al. TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin. 2009;41:648\u2013656.","journal-title":"Acta Biochim Biophys Sin"},{"key":"3706_CR17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1083\/jcb.200603013","volume":"174","author":"D Vignjevic","year":"2006","unstructured":"Vignjevic D, Kojima S, Aratyn Y, et al. Role of fascin in filopodial protrusion. J Cell Biol. 2006;174:863\u2013875.","journal-title":"J Cell Biol"},{"key":"3706_CR18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cub.2009.12.035","volume":"20","author":"A Li","year":"2010","unstructured":"Li A, Dawson JC, Forero-Vargas M, et al. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol. 2010;20:339\u2013345.","journal-title":"Curr Biol"},{"key":"3706_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4161\/cib.3.3.11556","volume":"3","author":"LM Machesky","year":"2010","unstructured":"Machesky LM, Li A. Fascin: invasive filopodia promoting metastasis. Commun Integr Biol. 2010;3:263\u2013270.","journal-title":"Commun Integr Biol"},{"key":"3706_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PGP.0b013e318183cfde","volume":"28","author":"YH Wen","year":"2009","unstructured":"Wen YH, Yee H, Goswami S, et al. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy. Int J Gynecol Pathol. 2009;28:187\u2013192.","journal-title":"Int J Gynecol Pathol"},{"key":"3706_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jso.21377","volume":"100","author":"T Iguchi","year":"2009","unstructured":"Iguchi T, Aishima S, Umeda K, et al. Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol. 2009;100:575\u2013579.","journal-title":"J Surg Oncol"},{"key":"3706_CR22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1349-7006.2011.01910.x","volume":"102","author":"Y Hayashi","year":"2011","unstructured":"Hayashi Y, Osanai M, Lee GH. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases. Cancer Sci. 2011;102:1228\u20131235.","journal-title":"Cancer Sci"},{"key":"3706_CR23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/nar\/gkr730","volume":"40","author":"Q Xu","year":"2012","unstructured":"Xu Q, Liu LZ, Qian X, et al. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012;40:761\u2013774.","journal-title":"Nucleic Acids Res"},{"key":"3706_CR24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/cdd.2009.117","volume":"17","author":"R Spizzo","year":"2010","unstructured":"Spizzo R, Nicoloso MS, Lupini L, et al. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ. 2010;17:246\u2013254.","journal-title":"Cell Death Differ"},{"key":"3706_CR25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bbrc.2014.03.107","volume":"446","author":"Y Wang","year":"2014","unstructured":"Wang Y, Hu C, Cheng J, et al. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling. Biochem Biophys Res Commun. 2014;446:1255\u20131260.","journal-title":"Biochem Biophys Res Commun"},{"key":"3706_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.2013.676","volume":"110","author":"N Akanuma","year":"2014","unstructured":"Akanuma N, Hoshino I, Akutsu Y, et al. MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer. 2014;110:189\u2013198.","journal-title":"Br J Cancer"},{"key":"3706_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2407-12-51","volume":"12","author":"ZS Wu","year":"2012","unstructured":"Wu ZS, Wang CQ, Xiang R, et al. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer. 2012;12:51.","journal-title":"BMC Cancer"},{"key":"3706_CR28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bjc.6605570","volume":"102","author":"T Chiyomaru","year":"2010","unstructured":"Chiyomaru T, Enokida H, Tatarano S, et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010;102:883\u2013891.","journal-title":"Br J Cancer"},{"key":"3706_CR29","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/ijc.25284","volume":"127","author":"M Kano","year":"2010","unstructured":"Kano M, Seki N, Kikkawa N, et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer. 2010;127:2804\u20132814.","journal-title":"Int J Cancer"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3706-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3706-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:22:13Z","timestamp":1599265333000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3706"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3706-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]}}}